LINC01315 is upregulated in colorectal cancer (CRC) (38) and osteosarcoma (OS) (39) and has been validated as a novel methylation-related prognostic biomarker in lung adenocarcinoma (LUAD) (40) and laryngeal squamous cell carcinoma (LSCC) (41). This evidence concerns the gene LINC01315 and colorectal carcinoma.